Press Releases

Summary ToggleProLungdx EPN Scan® Confirms Performance in Early Lung Cancer Risk Assessment

May 18, 2016

ProLungdx EPN Scan® Confirms Performance in Early Lung Cancer Risk Salt Lake City, Utah, USA, May 18, 2016 –  Fresh Medical Laboratories, Inc., doing business as ProLungdx™, today announced the initial results of its ongoing European Lung Cancer Registry.